DORC

Leading provider of instruments and equipment for vitreoretinal surgery


Established in 1983, D.O.R.C. is a leading provider of innovative instruments and equipment for ophthalmic surgery. The product range includes high precision disposable and re-usable instruments, surgical liquids and surgical machinery that is used for vitreoretinal and cataract procedures. Headquartered in Zuidland, the Netherlands, D.O.R.C. serves a global customer base including surgical centres, hospitals and physicians across the US, Europe, the mid-East, Asia and South America. The Company has more than 500 employees worldwide.

Montagu completed the acquisition of DORC in February 2014, from a consortium of shareholders including Rabo Capital, Van Lanschot Participaties and Oftavinci B.V.

Over its five years of ownership, Montagu significantly strengthened D.O.R.C.’s management team, helping the Company to become one of the key global players in the eye surgery market and the only platform of scale independent from corporates. During this period, D.O.R.C has achieved consistent double-digit growth and significant market share gains in Europe and the US.

Montagu sold D.O.R.C to Eurazeo Capital in April 2019

Deal details

Deal type: Management Buyout Investment Year: 2014 Country: BeNeLux Status: Realised Value: Undisclosed Industry Sector: Healthcare

http://www.dorc.eu